Metabolic regulation of behavior by the intestinal enzyme FMO-2
Science Advances · 2025
DOI: 10.1126/sciadv.adx3018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Elizabeth S Kitto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Integrative Physiology Department, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Oxygenases, Caenorhabditis elegans Proteins, Behavior, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Many elements of an organism’s behavior are intertwined with the organism’s health. Over a long period of time, health status is also indicative of life span, with improved health correlating with a longer life. However, the relationship between longevity and behavior remains relatively unexplored. Here, we report that modification of a single longevity gene downstream of dietary restriction and hypoxia markedly alters behavior in Caenorhabditis elegans . We found that modified expression of flavin-containing monooxygenase ( fmo-2 ) leads to altered sensory perception and decision-making in a variety of behavioral paradigms. This cell nonautonomous signaling pathway is linked to changes in tryptophan metabolism, where loss of fmo-2 requires the tryptophan metabolite serotonin and overexpressed fmo-2 requires the tryptophan metabolite quinolinic acid to change behavior. These results suggest a unique mechanism for gut metabolism to communicate positive satiety signals and negative depressive signals to the organism by modifying an essential amino acid. They also demonstrate the importance of examining pleiotropic effects in promising longevity interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular and Integrative Physiology Department, University of Michigan, Ann Arbor, MI, USA.
- Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, USA.
- Biomedical Research Core Facilities Metabolomics Core, University of Michigan, Ann Arbor, MI, USA.
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
ORCID-Profile: Elizabeth S Kitto, Safa Beydoun, Megan L Schaller, Mira Bhandari, Sarah A Easow, Angela M Tuckowski, Ajay Bhat, Charles R Evans, Scott F Leiser
Förderung
- NIA NIH HHS
Zitieren
APA
Kitto, E. S., Beydoun, S., Henry, E., Schaller, M. L., Bhandari, M., Easow, S. A., Tuckowski, A. M., Howington, M. B., Bhat, A., Sridhar, A., Chung, E., Evans, C. R., & Leiser, S. F. (2025). Metabolic regulation of behavior by the intestinal enzyme FMO-2. Science Advances. https://doi.org/10.1126/sciadv.adx3018
Vancouver
Kitto ES, Beydoun S, Henry E, Schaller ML, Bhandari M, Easow SA, et al. Metabolic regulation of behavior by the intestinal enzyme FMO-2. Science Advances. 2025. doi:10.1126/sciadv.adx3018
BibTeX
@article{Kitto2025,
author = {Kitto, Elizabeth S and Beydoun, Safa and Henry, Ella and Schaller, Megan L and Bhandari, Mira and Easow, Sarah A and Tuckowski, Angela M and Howington, Marshall B and Bhat, Ajay and Sridhar, Aditya and Chung, Eugene and Evans, Charles R and Leiser, Scott F},
title = {Metabolic regulation of behavior by the intestinal enzyme FMO-2},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx3018}
}
EUVIMED